PPP2R1A, a well-characterized scaffold subunit of the PP2A complex [25], has been reported to decrease the cytotoxicity of chemoradiation treatment in pancreatic cancer via activating HRR and inhibiting CDC25/and CDK1 [26]. The gene discussed is PTPA; the disease is pancreatic neoplasm.